Literature DB >> 15749499

Antiphospholipid antibodies prevent extravillous trophoblast differentiation.

Siobhan Quenby1, Steve Mountfield, Judith E Cartwright, Guy StJ Whitley, Larry Chamley, Gill Vince.   

Abstract

OBJECTIVE: We investigated the hypothesis that antiphospholipid antibodies (aPL) have a detrimental effect on human extravillous trophoblast (EVT) differentiation into giant multinucleated cells "in vitro."
DESIGN: The EVT were isolated from the placental chorion using enzymatic digestion and Percoll gradient centrifugation. After 24, 36, and 48 hours in culture, giant multinuclear cells (GMC) were identified by immunohistochemistry using antibodies to cytokeratin 7 and counted.
SETTING: An academic research laboratory. PATIENT(S): Placentas were donated by women having an elective cesarean section for a normal pregnancy at term. MAIN OUTCOME MEASURE(S): This model was then used to investigate the effect of two different monoclonal aPL to beta2-glycoprotein 1 (IIC5 and ID2), and control mouse IgG antibody on EVT differentiation. RESULT(S): Freshly isolated EVT were nonproliferative but moved together losing their intervening cell walls and differentiated into GMC. Maximal numbers of GMC were detected after 48 hours of culture. The aPL, IIC5, and ID2 significantly inhibited GMC formation, whereas the mouse IgG control had no effect. CONCLUSION(S): Antiphospholipid antibodies can inhibit EVT differentiation and GMC formation "in vitro" suggesting that a failure of trophoblast differentiation and subsequent uteroplacental development may be an underlying pathology in antiphospholipid syndrome-associated pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749499     DOI: 10.1016/j.fertnstert.2004.07.978

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome.

Authors:  Mayumi Sugiura-Ogasawara; Yosuke Omae; Minae Kawashima; Licht Toyo-Oka; Seik-Soon Khor; Hiromi Sawai; Tetsuya Horita; Tatsuya Atsumi; Atsuko Murashima; Daisuke Fujita; Tomio Fujita; Shinji Morimoto; Eriko Morishita; Shinji Katsuragi; Tamao Kitaori; Kinue Katano; Yasuhiko Ozaki; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2017-04-20       Impact factor: 3.172

2.  Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.

Authors:  Zola Chihombori Quao; Mancy Tong; Elena Bryce; Seth Guller; Lawrence W Chamley; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2017-11-14       Impact factor: 3.886

3.  Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway.

Authors:  Melissa J Mulla; Jan J Brosens; Larry W Chamley; Ian Giles; Charis Pericleous; Anisur Rahman; Shawna K Joyce; Britta Panda; Michael J Paidas; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2009-08       Impact factor: 3.886

Review 4.  Autoimmunity and recurrent pregnancy losses.

Authors:  Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

5.  Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.

Authors:  Stefan M Gysler; Melissa J Mulla; Marta Guerra; Jan J Brosens; Jane E Salmon; Lawrence W Chamley; Vikki M Abrahams
Journal:  Mol Hum Reprod       Date:  2016-03-29       Impact factor: 4.025

6.  Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators.

Authors:  Melissa J Mulla; Ingrid C Weel; Julie A Potter; Stefan M Gysler; Jane E Salmon; Maria T S Peraçoli; Carla V Rothlin; Lawrence W Chamley; Vikki M Abrahams
Journal:  Arthritis Rheumatol       Date:  2018-04-25       Impact factor: 10.995

7.  ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.

Authors:  Paulien G de Jong; Siobhan Quenby; Kitty W M Bloemenkamp; Babette A M Braams-Lisman; Jan Peter de Bruin; Arri Coomarasamy; Michele David; Maria T DeSancho; Olivier W H van der Heijden; Annemieke Hoek; Barbara A Hutten; Kristin Jochmans; Carolien A M Koks; Walter K M Kuchenbecker; Ben Willem J Mol; Helen L Torrance; Hubertina C J Scheepers; Mary D Stephenson; Harold R Verhoeve; Jantien Visser; Johanna I P de Vries; Mariëtte Goddijn; Saskia Middeldorp
Journal:  Trials       Date:  2015-05-07       Impact factor: 2.279

Review 8.  Female Unexplained Infertility: A Disease with Imbalanced Adaptive Immunity.

Authors:  Motahareh Ehsani; Mousa Mohammadnia-Afrouzi; Mohammad Mirzakhani; Sedighe Esmaeilzadeh; Mehdi Shahbazi
Journal:  J Hum Reprod Sci       Date:  2019-12-17

9.  A novel human endogenous retroviral protein inhibits cell-cell fusion.

Authors:  Jun Sugimoto; Makiko Sugimoto; Helene Bernstein; Yoshihiro Jinno; Danny Schust
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  The term basal plate of the human placenta as a source of functional extravillous trophoblast cells.

Authors:  Alexandre U Borbely; Silvana Sandri; Isabella R Fernandes; Karen M Prado; Elaine C Cardoso; Simone Correa-Silva; Renata Albuquerque; Martin Knöfler; Patricia Beltrão-Braga; Ana Campa; Estela Bevilacqua
Journal:  Reprod Biol Endocrinol       Date:  2014-01-28       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.